Evidence map›Paper›PMID 40785180›Full record

ArticleCurrent drug metabolism2025

Influence of Orange Oil on Skin Permeability, Dermatokinetics, and

Narahari N Palei, Arghya K Dhar, Jayaraman Rajangam, Dharani Prasad P, Biswa Mohan Sahoo

Abstract read
PubMed Publisher
In one paragraph

Article in Current drug metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Narahari N PaleiAmity Institute of Pharmacy, Amity University Uttar Pradesh, Lucknow, India.ORCID 0000-0002-2041-1849
Arghya K DharSchool of Pharmacy, The Neotia University, Sarisha, West Bengal, India.ORCID 0000-0003-1081-9143
Jayaraman RajangamShri Venkateshwara College of Pharmacy, Ariyur, Puducherry, India.ORCID 0000-0002-6367-0365
Dharani Prasad PMB School of Pharmaceutical Sciences, Mohan Babu University, Tirupati, India.ORCID 0009-0008-8608-8790
Biswa Mohan SahooSchool of Pharmacy and Life Sciences, Centurion University of Technology and Management, Bhubaneswar, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLornoxicam is a non-steroidal anti-inflammatory drug belonging to the oxicam class. This study aimed to develop a niosomal gel containing orange oil for improving the anti-inflammatory effect of lornoxicam.

methodsLornoxicam-loaded niosomes (LOR-OR-NIO) were prepared using film hydration followed by the sonication method. Particle size, entrapment efficiency, and

resultsThe particle size, entrapment efficiency, and skin permeation ability of the optimized LOR-ORNIO formulation were found to be 354.3 nm, 83.56 %, and 105.63 μg/cm2, respectively. The ex vivo studies indicated that the optimized LOR-OR-NIO gel demonstrated superior drug penetration properties (105.43 μg/cm DISCUSSION: The lower activation energy of the LOR-OR-NIO gel contributed to more skin penetration of the drug. Dermatokinetics investigation demonstrated that the LOR-OR-NIO gel had superior penetration in the epidermal and dermal areas compared to the LOR gel.

conclusionThe study concluded that orange oil enhanced skin permeability and influenced the dermatokinetics of the LOR-OR-NIO gel, leading to an improvement in

Indexed as

Anti-Inflammatory Agents, Non-SteroidalPiroxicamPlant OilsSkin AbsorptionAdministration, CutaneousAnimalsEdemaGelsLiposomesMaleParticle SizePermeabilityRatsRats, WistarSkinAnti-Inflammatory Agents, Non-SteroidalGelsLiposomeslornoxicamorange oilPiroxicamPlant Oilsdermatokineticsin vivo studies.Lornoxicamniosomesoptimizationorange oil

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.